Search

everythinglearnresearchcommunity

for

Search:↓

A synthetic drug and a South American herb may help treat alopecia areata in Chinese men.

DNCB is highly effective for treating alopecia areata with minimal long-term side effects.

Baricitinib helped treat a man's beard hair loss when steroids didn't work.

A vibrating anesthetic device significantly reduces pain during mesotherapy for hair loss without complications.

New tools help doctors better assess and treat alopecia areata in kids by considering more than just hair loss.

The model predicts minoxidil's effectiveness and side effects better than traditional methods.

A Gsdma3 mutation causes hair loss due to stem cell damage from skin inflammation.

The Free Androgen Index (FAI) is the best indicator of early hair loss in men before age 30.

Some treatments can help with a hair loss condition called alopecia areata, but none ensure lasting results; choices depend on the person, with JAK inhibitors showing promise for severe cases.

Polydopamine is promising for personalized medicine and biomedical technology due to its strong adhesion and biocompatibility.

Minoxidil helps hair regrowth by affecting hair follicles and blood vessels.

Serum IMA levels don't help diagnose AGA but may indicate its severity.

Alopecia areata requires addressing both emotional and financial challenges for better patient care.

Modified frameworks with stearic acid enhance drug delivery and promote hair growth.

A specific gene change is linked to severe hair loss.

Mutations in the androgen receptor gene cause androgen insensitivity, leading to female traits in genetically male individuals.

The framework helps predict adverse effects of blood thinners, improving drug selection for atrial fibrillation.

Minoxidil was promising for treating male and female pattern baldness in 1994, but more research on genetics and other treatments was needed.

Alopecia Areata is often linked to other health issues like allergies, thyroid problems, and diabetes.

The compounds tested could potentially treat hair loss and alopecia.

Alopecia areata in Saudi Arabia is costly, mainly due to lost productivity and drug costs.

Contact immunotherapy can change immune responses in alopecia areata, suggesting new treatment targets.

Alopecia areata in Asia causes significant hair loss and psychological distress, with high costs and a need for more research.

The AI system HairComb accurately scores hair loss severity, matching dermatologist assessments.

ASA and CM may protect the brain and work better together.

Specific mutations in a receptor cause facial abnormalities and hair loss.

The Turkish version of the MAIA-2 Scale is valid and reliable for patients at a dermatology clinic.

CD28 is a promising target for treating alopecia areata with belatacept.

CD28 is a promising target for treating alopecia areata with belatacept.

Lasers and energy-assisted methods show promise for treating hair loss, but more research is needed.